Michael Wayne Kalb is Executive Vice President & CFO of Catalyst Pharmaceuticals Inc.
Person profile
Roles
Catalyst Pharmaceuticals
Executive Vice President & CFO
CinCor Pharma
EVP & Chief Financial Officer
Address
Dix Hills, New York
Employees
SEC CIK
Latest filings (excl ownership)
No filings
Latest ownership filings
3
CATALYST PHARMACEUTICALS, INC.
3 Jan 24
4
IMPEL PHARMACEUTICALS INC
12 May 23
3
IMPEL PHARMACEUTICALS INC
12 May 23
4
CinCor Pharma, Inc.
24 Feb 23
4
CinCor Pharma, Inc.
30 Jan 23
4
CinCor Pharma, Inc.
8 Nov 22
3
CinCor Pharma, Inc.
8 Nov 22
4
AMARIN CORP PLC\UK
2 Aug 22
4
AMARIN CORP PLC\UK
2 Mar 22
4
AMARIN CORP PLC\UK
8 Feb 22
Recent insider trades
Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
10 May 23 | IMPLQ Impel Pharmaceuticals | RSU Common Stock | Grant | Acquire A | No | No | 0 | 47,500 | 0.00 | 47,500 |
10 May 23 | IMPLQ Impel Pharmaceuticals | Stock Option Common Stock | Grant | Acquire A | No | No | 2.43 | 175,000 | 425.25 k | 175,000 |
24 Feb 23 | CINC CinCor Pharma | Common Stock | Sale back to company | Dispose D | No | No | 0 | 202,437 | 0.00 | 0 |
24 Feb 23 | CINC CinCor Pharma | Stock Option Common Stock | Sale back to company | Dispose D | No | No | 30.07 | 77,615 | 2.33 mm | 0 |
26 Jan 23 | CINC CinCor Pharma | Common Stock | Grant | Acquire A | No | No | 0 | 177,000 | 0.00 | 202,437 |